On the other hand, enhancement of IL-22BPi2 and IL-22BPi3 production may be indicated to control the deleterious actions of IL-22 in psoriasis [19] and intestinal tumorigenesis, where IL-22BP prevents long-lasting proliferative actions of IL-22 on malignant epithelial cells [20]. The gene discussed is IL22; the disease is psoriasis.